Literature DB >> 10391445

Locus coeruleus neurons: cessation of activity during cataplexy.

M F Wu1, S A Gulyani, E Yau, E Mignot, B Phan, J M Siegel.   

Abstract

Cataplexy, a symptom of narcolepsy, is a loss of muscle tone usually triggered by sudden, emotionally significant stimuli. We now report that locus coeruleus neurons cease discharge throughout cataplexy periods in canine narcoleptics. Locus coeruleus discharge rates during cataplexy were as low as or lower than those seen during rapid-eye-movement sleep. Prazosin, an alpha1 antagonist, and physostigmine, a cholinesterase inhibitor, both of which precipitate cataplexy, decreased locus coeruleus discharge rate. Our results are consistent with the hypothesis that locus coeruleus activity contributes to the maintenance of muscle tone in waking, and that reduction in locus coeruleus discharge plays a role in the loss of muscle tone in cataplexy and rapid-eye-movement sleep. Our results also show that the complete cessation of locus coeruleus activity is not sufficient to trigger rapid-eye-movement sleep in narcoleptics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391445      PMCID: PMC8848839          DOI: 10.1016/s0306-4522(98)00600-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  53 in total

1.  Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups.

Authors:  J A Hobson; R W McCarley; P W Wyzinski
Journal:  Science       Date:  1975-07-04       Impact factor: 47.728

2.  ACh, substance P and met-enkephalin in the locus coeruleus: pharmacological evidence for independent sites of action.

Authors:  P G Guyenet; G K Aghajanian
Journal:  Eur J Pharmacol       Date:  1979-02-01       Impact factor: 4.432

Review 3.  The locus coeruleus: neurobiology of a central noradrenergic nucleus.

Authors:  D G Amaral; H M Sinnamon
Journal:  Prog Neurobiol       Date:  1977       Impact factor: 11.685

4.  Effects of locus coeruleus lesions on auditory, long-latency, event-related potentials in monkey.

Authors:  J A Pineda; S L Foote; H J Neville
Journal:  J Neurosci       Date:  1989-01       Impact factor: 6.167

Review 5.  Noradrenergic and cholinergic mechanisms responsible for the gain regulation of vestibulospinal reflexes.

Authors:  P D'Ascanio; O Pompeiano; G Stampacchia
Journal:  Prog Brain Res       Date:  1988       Impact factor: 2.453

6.  Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle.

Authors:  G Aston-Jones; F E Bloom
Journal:  J Neurosci       Date:  1981-08       Impact factor: 6.167

7.  Extranuclear dendrites of locus coeruleus neurons: activation by glutamate and modulation of activity by alpha adrenoceptors.

Authors:  A Ivanov; G Aston-Jones
Journal:  J Neurophysiol       Date:  1995-12       Impact factor: 2.714

8.  Mutual interactions among cholinergic, noradrenergic and serotonergic neurons studied by ionophoresis of these transmitters in rat brainstem nuclei.

Authors:  Y Koyama; Y Kayama
Journal:  Neuroscience       Date:  1993-08       Impact factor: 3.590

9.  Blockade of alpha 2-adrenoceptors increases opioid mu-receptor-mediated inhibition of the firing rate of rat locus coeruleus neurones.

Authors:  P Illes; W Nörenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-11       Impact factor: 3.000

10.  Noradrenaline innervation of the spinal cord studied by the horseradish peroxidase method combined with monoamine oxidase staining.

Authors:  K Satoh; M Tohyama; K Yamamoto; T Sakumoto; N Shimizu
Journal:  Exp Brain Res       Date:  1977-11-24       Impact factor: 1.972

View more
  80 in total

1.  Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons.

Authors:  P Bourgin; S Huitrón-Résendiz; A D Spier; V Fabre; B Morte; J R Criado; J G Sutcliffe; S J Henriksen; L de Lecea
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Activation of pontine and medullary motor inhibitory regions reduces discharge in neurons located in the locus coeruleus and the anatomical equivalent of the midbrain locomotor region.

Authors:  B Y Mileykovskiy; L I Kiyashchenko; T Kodama; Y Y Lai; J M Siegel
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

3.  Cessation of activity in red nucleus neurons during stimulation of the medial medulla in decerebrate rats.

Authors:  Boris Y Mileykovskiy; Lyudmila I Kiyashchenko; Jerome M Siegel
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

4.  Release of hypocretin (orexin) during waking and sleep states.

Authors:  Lyudmila I Kiyashchenko; Boris Y Mileykovskiy; Nigel Maidment; Hoa A Lam; Ming-Fung Wu; Joshi John; John Peever; Jerome M Siegel
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

Review 5.  Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.

Authors:  Steven T Szabo; Michael J Thorpy; Geert Mayer; John H Peever; Thomas S Kilduff
Journal:  Sleep Med Rev       Date:  2018-11-08       Impact factor: 11.609

6.  Activation of cortical interneurons during sleep: an anatomical link to homeostatic sleep regulation?

Authors:  Thomas S Kilduff; Bruno Cauli; Dmitry Gerashchenko
Journal:  Trends Neurosci       Date:  2010-10-26       Impact factor: 13.837

Review 7.  [The neurophysiology of cataplexy].

Authors:  G Mayer
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

8.  Glutamate receptor subunit expression in the rhesus macaque locus coeruleus.

Authors:  Nigel C Noriega; Vasilios T Garyfallou; Steven G Kohama; Henryk F Urbanski
Journal:  Brain Res       Date:  2007-08-09       Impact factor: 3.252

Review 9.  Clinical and neurobiological aspects of narcolepsy.

Authors:  Seiji Nishino
Journal:  Sleep Med       Date:  2007-04-30       Impact factor: 3.492

10.  A consensus definition of cataplexy in mouse models of narcolepsy.

Authors:  Thomas E Scammell; Jon T Willie; Christian Guilleminault; Jerome M Siegel
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.